Skip to content

G-CREDIT (Gangnam-Cohort for Risk Evaluation of Diabetes and Impaired Glucose Tolerance)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02726256
Enrollment
500
Registered
2016-04-01
Start date
2007-01-31
Completion date
2026-02-28
Last updated
2016-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired Glucose Intolerance, Type 2 Diabetes

Keywords

Diabetes, DM complication

Brief summary

The prevalence of type 2 diabetes has consistently increased and type 2 diabetes can cause many types of vascular complications. Diabetes develops due to glucose intolerance. Early detection and intervention in the stage of glucose intolerance makes it afford to prevent overt diabetes and its complications. This study was designed to make a cohort of korean patients with glucose intolerance to construct a long term database about clinical characteristics of these patients.

Interventions

None listed

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

1. Patients older than 20 years old who has visited Gangnam severance hospital since January 2007. 2. Patients with either diabetes or impaired glucose tolerance 3. Patients with at least 6 months of follow-up period

Exclusion criteria

1\. Patients with gestational diabetes, any active stage of cancer and severe disability

Design outcomes

Primary

MeasureTime frameDescription
Life style assessment - Past medical history - Smoking, alcohol history - Sleep, exercise, daily activity check - Diet - Reproductive status (Women only) - Socioeconomic statusan expected average of 12 weeksMeasuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Past medical historyan expected average of 12 weeksMeasuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Smoking, alcohol historyan expected average of 12 weeksMeasuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Sleep, exercise, daily activity checkan expected average of 12 weeksMeasuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Dietan expected average of 12 weeksMeasuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Reproductive status (Women only)an expected average of 12 weeksMeasuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Socioeconomic statusan expected average of 12 weeksMeasuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Anthropometric measurements : Height, weight, waist circumference, pulse rate, blood pressurean expected average of 12 weeksMeasuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
SMA, TG, HDL, LDLM apoA, apoBan expected average of 12 weeksMeasuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
PC2hrs, HbA1C, Insulin, C-peptide (AC, PC2hr), hs-CRPan expected average of 12 weeksMeasuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Urine protein, albumin, creatininean expected average of 12 weeksMeasuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
EKG, Neurometer, Chest PA, Abdominal sonographyan expected average of 12 weeksMeasuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Fundus photography, fat computed tomographyan expected average of 12 weeksMeasuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
HOMA-IR, HOMA-βan expected average of 12 weeksMeasuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications

Contacts

Primary ContactChul Woo Ahn, MD
acw@yuhs.ac82-02-2019-3339

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026